CGC Stock: Canopy Growth Corporation Stock Price, Analysis & Insights
Get live cgc stock price $1.92, comprehensive Canopy Growth Corporation stock analysis, charts, news, and expert forecast. Real-time cgc stock data and investment insights.
Loading chart...
Company Overview
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. It offers its products under the Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, and Truverra brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.
Company Information
- CEO
- Luc Mongeau
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Employees
- 1029
Contact Information
- Website
- https://www.canopygrowth.com
- Address
- 1 Hershey Drive
- Country
- CA
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Higher growth potential with elevated volatility (Beta: 2.14)
Business Model & Strategy
Canopy Growth Corporation operates in the Drug Manufacturers - Specialty & Generic industry, focusing on medical services, pharmaceutical development, and healthcare delivery. Under the leadership of CEO Luc Mongeau, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Drug Manufacturers - Specialty & Generic model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
Canopy Growth Corporation competes in the Drug Manufacturers - Specialty & Generic within the broader Healthcare. With 460.4 million in market capitalization, the company is positioned as a emerging competitor in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the NASDAQ Global Select, Canopy Growth Corporation provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating Canopy Growth Corporation should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Canopy Growth Corporation shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Canopy Growth Corporation
- ⚠Investors should consider how Canopy Growth Corporation fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
460.38M
P/E Ratio
-0.95
Beta
2.14
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 460.38M market capitalization
- Trading Volume: 101.27M shares traded today
- Price Range: 52-week range of $0.77 - $3.07
- Exchange: Listed on NASDAQ Global Select
Financial Metrics
Market Analysis for Canopy Growth Corporation
Canopy Growth Corporation (CGC) operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. With a current market capitalization of 460.38M, the company represents a significant player in its market. The stock is currently trading at $1.92 with a positivedaily change of 4.92%.
The company's 1029 employee base and presence on the NASDAQ Global Selectexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of -0.95, beta of 2.14, and 52-week price range from $0.77 to $3.07when evaluating investment opportunities.
Why Invest in Canopy Growth Corporation?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (NASDAQ Global Select)
- • Experienced leadership under Luc Mongeau
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.